Annual Current Assets
$7.44 M
-$16.97 M-69.51%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual total current assets is $7.44 million, with the most recent change of -$16.97 million (-69.51%) on December 31, 2023.
- During the last 3 years, CYCC annual current assets has fallen by -$28.02 million (-79.01%).
- CYCC annual current assets is now -88.33% below its all-time high of $63.78 million, reached on December 31, 2007.
Performance
CYCC Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$4.91 M
-$2.79 M-36.25%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly total current assets is $4.91 million, with the most recent change of -$2.79 million (-36.25%) on September 30, 2024.
- Over the past year, CYCC quarterly current assets has dropped by -$2.53 million (-34.00%).
- CYCC quarterly current assets is now -94.24% below its all-time high of $85.23 million, reached on March 31, 2007.
Performance
CYCC Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CYCC Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.5% | -34.0% |
| 3 y3 years | -79.0% | -74.1% |
| 5 y5 years | -62.4% | -74.1% |
CYCC Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.8% | at low | -88.0% | +1.6% |
| 5 y | 5-year | -81.8% | at low | -90.3% | +1.6% |
| alltime | all time | -88.3% | at low | -94.2% | +1.6% |
Cyclacel Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.91 M(-36.3%) |
| Jun 2024 | - | $7.71 M(+59.4%) |
| Mar 2024 | - | $4.83 M(-35.0%) |
| Dec 2023 | $1.36 M(-62.6%) | $7.44 M(-33.0%) |
| Sep 2023 | - | $11.11 M(-27.3%) |
| Jun 2023 | - | $15.29 M(-19.4%) |
| Mar 2023 | - | $18.97 M(-22.3%) |
| Dec 2022 | $3.64 M(+65.9%) | $24.41 M(-12.6%) |
| Sep 2022 | - | $27.91 M(-13.0%) |
| Jun 2022 | - | $32.08 M(-12.3%) |
| Mar 2022 | - | $36.58 M(-10.7%) |
| Dec 2021 | $2.19 M(+64.7%) | $40.94 M(-5.6%) |
| Sep 2021 | - | $43.38 M(-6.1%) |
| Jun 2021 | - | $46.20 M(-8.4%) |
| Mar 2021 | - | $50.46 M(+42.3%) |
| Dec 2020 | $1.33 M(+3.2%) | $35.47 M(+36.8%) |
| Sep 2020 | - | $25.93 M(-7.2%) |
| Jun 2020 | - | $27.93 M(+136.5%) |
| Mar 2020 | - | $11.81 M(-15.7%) |
| Dec 2019 | $1.29 M(+3486.1%) | $14.02 M(-11.5%) |
| Sep 2019 | - | $15.84 M(-12.7%) |
| Jun 2019 | - | $18.15 M(-9.8%) |
| Mar 2019 | - | $20.12 M(+1.7%) |
| Dec 2018 | $36.00 K(+24.1%) | $19.79 M(-4.3%) |
| Sep 2018 | - | $20.67 M(-8.9%) |
| Jun 2018 | - | $22.69 M(-8.3%) |
| Mar 2018 | - | $24.73 M(-4.8%) |
| Dec 2017 | $29.00 K(-35.6%) | $25.97 M(-6.6%) |
| Sep 2017 | - | $27.82 M(+73.3%) |
| Jun 2017 | - | $16.05 M(-5.8%) |
| Mar 2017 | - | $17.03 M(-13.2%) |
| Dec 2016 | $45.00 K(-77.3%) | $19.62 M(-13.1%) |
| Sep 2016 | - | $22.58 M(+20.3%) |
| Jun 2016 | - | $18.77 M(-11.9%) |
| Mar 2016 | - | $21.31 M(-13.3%) |
| Dec 2015 | $198.00 K(-48.8%) | $24.57 M(-8.3%) |
| Sep 2015 | - | $26.79 M(-12.1%) |
| Jun 2015 | - | $30.48 M(-13.0%) |
| Mar 2015 | - | $35.02 M(+20.8%) |
| Dec 2014 | $387.00 K | $29.00 M(-7.0%) |
| Sep 2014 | - | $31.18 M(-16.4%) |
| Jun 2014 | - | $37.28 M(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $33.45 M(-4.9%) |
| Dec 2013 | $347.00 K(-28.0%) | $35.17 M(-6.7%) |
| Sep 2013 | - | $37.72 M(+1.5%) |
| Jun 2013 | - | $37.16 M(+118.2%) |
| Mar 2013 | - | $17.03 M(-9.8%) |
| Dec 2012 | $482.00 K(+188.6%) | $18.87 M(-5.4%) |
| Sep 2012 | - | $19.95 M(-7.9%) |
| Jun 2012 | - | $21.65 M(-14.0%) |
| Mar 2012 | - | $25.17 M(-2.6%) |
| Dec 2011 | $167.00 K(-59.1%) | $25.83 M(-10.2%) |
| Sep 2011 | - | $28.78 M(+28.2%) |
| Jun 2011 | - | $22.45 M(-16.4%) |
| Mar 2011 | - | $26.87 M(-13.5%) |
| Dec 2010 | $408.00 K(-62.8%) | $31.05 M(+57.8%) |
| Sep 2010 | - | $19.68 M(-8.5%) |
| Jun 2010 | - | $21.51 M(-16.8%) |
| Mar 2010 | - | $25.86 M(+93.5%) |
| Dec 2009 | $1.10 M(-43.5%) | $13.37 M(-17.6%) |
| Sep 2009 | - | $16.23 M(-9.7%) |
| Jun 2009 | - | $17.97 M(-23.3%) |
| Mar 2009 | - | $23.43 M(-19.2%) |
| Dec 2008 | $1.94 M(-84.0%) | $29.01 M(-22.2%) |
| Sep 2008 | - | $37.31 M(-18.6%) |
| Jun 2008 | - | $45.81 M(-15.6%) |
| Mar 2008 | - | $54.31 M(-14.8%) |
| Dec 2007 | $12.13 M(+137.4%) | $63.78 M(-15.2%) |
| Sep 2007 | - | $75.17 M(-6.3%) |
| Jun 2007 | - | $80.25 M(-5.8%) |
| Mar 2007 | - | $85.23 M(+46.5%) |
| Dec 2006 | $5.11 M(+149.9%) | $58.16 M(-7.6%) |
| Sep 2006 | - | $62.96 M(-7.3%) |
| Jun 2006 | - | $67.95 M(+99.8%) |
| Mar 2006 | - | $34.00 M(+99.7%) |
| Dec 2005 | $2.04 M(-71.8%) | $17.03 M(-37.8%) |
| Sep 2005 | - | $27.37 M(-18.9%) |
| Jun 2005 | - | $33.75 M(-17.7%) |
| Mar 2005 | - | $41.00 M(-15.2%) |
| Dec 2004 | $7.26 M(+63.6%) | $48.34 M(+71.2%) |
| Sep 2004 | - | $28.24 M(-19.3%) |
| Jun 2004 | - | $35.01 M(-15.1%) |
| Mar 2004 | - | $41.24 M(+193.3%) |
| Dec 2003 | $4.44 M | $14.06 M |
FAQ
- What is Cyclacel Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual current assets year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly current assets year-on-year change?
What is Cyclacel Pharmaceuticals annual total current assets?
The current annual current assets of CYCC is $7.44 M
What is the all time high annual current assets for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual total current assets is $63.78 M
What is Cyclacel Pharmaceuticals annual current assets year-on-year change?
Over the past year, CYCC annual total current assets has changed by -$16.97 M (-69.51%)
What is Cyclacel Pharmaceuticals quarterly total current assets?
The current quarterly current assets of CYCC is $4.91 M
What is the all time high quarterly current assets for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly total current assets is $85.23 M
What is Cyclacel Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, CYCC quarterly total current assets has changed by -$2.53 M (-34.00%)